首页> 外文期刊>World Journal of Cardiovascular Surgery >Assessing Safety of CABG in the Era Post Primary PCI, an Outcome Analysis of STEMI Population
【24h】

Assessing Safety of CABG in the Era Post Primary PCI, an Outcome Analysis of STEMI Population

机译:评估PCI后时代CABG的安全性,STEMI人群的结果分析

获取原文
           

摘要

Background: Primary PCI (PPCI) has replaced thrombolysis as the treatment of choice for STEMI. The effect of this change on outcomes of patients referred for subsequent CABG is unknown. Methods: All STEMI patients having thrombolysis or PPCI between 2000 and 2010 were identified. Of these, patients subsequently referred for isolated first time CABG form the cohort for this study. Results: 83 of 2476 (3.4%) patients from the PPCI cohort (median follow-up [FU] 3 years [range 6 m - 7.8 y]) and 49 of 528 (9.2%) from the thrombolysis cohort (median FU 9 y [range 1.5 - 10 y] were referred for subsequent CABG. In this referred group, initial reperfusion success (as defined) was: PPCI = 86%, lysis = 84%, p = 0.69. Surgical waiters with prior PPCI had less post infarct angina (1.2% vs. 25%, p 0.01) and late re-infarction (6% vs. 20%, p = 0.034) prior to surgery. Timing of CABG was: 6 m (PPCI 82%, lysis 73%), 6 m-1 y (PPCI 8.4%, lysis: 9%), >1 y (PPCI 9.6%, lysis 18%).Other than an increased prevalence of diabetes in the thrombolysis group, there were no differences in demographic details or risk profile. There were no post-operative deaths, MIs or CVAs. There were no significant differences in post-op AF (28% vs. 22% p = 0.5), respiratory failure (8% vs. 18%, p = 0.08), renal failure (5% vs. 6%, p = 0.5) or re-openings (0% vs. 6%, p = 0.8). Mortality at 3 years was 2.4% in the PPCI cohort and 4% in the thrombolysis cohort. Overall mortality during follow-up for the PPCI group was 3.6% (n = 3) (median FU 3 years), and for the lysis group was 24.5% (n = 12) (median FU 9 years). Conclusions: In patients awaiting CABG after STEMI, PPCI reduces the risk of post-infarct angina and re-infarction prior to surgery, but early surgical results were equally favorable in both groups. Additional follow-up is needed in the PPCI cohort to determine whether there are any significantly different longer-term outcomes.
机译:背景:原发性PCI(PPCI)替代了溶栓治疗,成为STEMI的首选治疗方法。这种变化对随后进行CABG转诊的患者预后的影响尚不清楚。方法:确定2000至2010年间所有有溶栓或PPCI的STEMI患者。在这些患者中,随后接受首次隔离CABG的患者构成了本研究的队列。结果:来自PPCI队列的2476名患者中有83名(3.4%)(中位随访[FU] 3年[范围6 m-7.8 y]),来自溶栓队列的528名患者中有49名(9.2%)(9.2%)(%FU) 9 y [范围1.5-10 y]用于随后的CABG。在该参照组中,初始再灌注成功率(定义为)为:PPCI = 86%,裂解= 84%,p = 0.69。术前较少发生梗死后心绞痛(1.2%vs. 25%,p = 0.01)和晚期再梗塞(6%vs. 20%,p = 0.034),CABG的时机为:6 m(PPCI) 82%,溶解度73%,6​​ m-1 y(PPCI 8.4%,溶解度9%),> 1年(PPCI 9.6%,溶解度18%)在溶栓治疗组中,人口统计学细节或风险特征无差异;术后死亡,MI或CVA无差异;术后房颤无显着差异(28%vs. 22%p = 0.5 ),呼吸衰竭(8%对18%,p = 0.08),肾衰竭(5%对6%,p = 0.5)或重新开放(0%对6%,p = 0.8)。 PPCI组的3年ty为2.4%,溶栓组的4%。 PPCI组随访期间的总死亡率为3.6%(n = 3)(中位FU 3年),裂解组的总死亡率为24.5%(n = 12)(中位FU 9年)。结论:在STEMI后等待CABG的患者中,PPCI降低了术前梗死后心绞痛和再次梗塞的风险,但两组的早期手术效果均相同。 PPCI队列还需要进一步的随访,以确定是否存在明显不同的长期结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号